Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 746 | 8 | 870 | 1,783 | 1,964 |
| Marketable Securities | N/A | N/A | N/A | N/A | 739 |
| Receivables | 312 | 99 | 68 | 28 | 17 |
| TOTAL | $1,102 | $134 | $1,060 | $1,831 | $2,739 |
| Non-Current Assets | |||||
| PPE Net | 5 | 2 | 1 | 3 | 4 |
| Investments And Advances | 0 | 0 | 0 | 2 | 32 |
| Intangibles | 0 | 0 | 0 | 16 | 31 |
| TOTAL | $5 | $2 | $1 | $21 | $67 |
| Total Assets | $1,107 | $136 | $1,061 | $1,852 | $2,805 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 609 | 614 | 222 | 104 | 83 |
| TOTAL | $609 | $614 | $222 | $104 | $83 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $609 | $614 | $222 | $104 | $83 |
| Shareholders' Equity | |||||
| Common Shares | 22,434 | 21,468 | 21,636 | 21,182 | 20,198 |
| Retained earnings | -27,870 | -26,823 | -25,720 | -24,245 | -22,046 |
| Other shareholders' equity | 1,076 | 1,598 | 2,201 | 2,155 | 2,055 |
| TOTAL | $498 | $-478 | $839 | $1,748 | $2,722 |
| Total Liabilities And Equity | $1,107 | $136 | $1,061 | $1,852 | $2,805 |